Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.
about
Brief Report: A Phase 1b/Pharmacokinetic Trial of PTC299, a Novel PostTranscriptional VEGF Inhibitor, for AIDS-Related Kaposi's Sarcoma: AIDS Malignancy Consortium Trial 059.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Brief Report: A Phase 1b/Pharm ...... lignancy Consortium Trial 059.
@ast
Brief Report: A Phase 1b/Pharm ...... lignancy Consortium Trial 059.
@en
type
label
Brief Report: A Phase 1b/Pharm ...... lignancy Consortium Trial 059.
@ast
Brief Report: A Phase 1b/Pharm ...... lignancy Consortium Trial 059.
@en
prefLabel
Brief Report: A Phase 1b/Pharm ...... lignancy Consortium Trial 059.
@ast
Brief Report: A Phase 1b/Pharm ...... lignancy Consortium Trial 059.
@en
P2093
P2860
P1476
Brief Report: A Phase 1b/Pharm ...... alignancy Consortium Trial 059
@en
P2093
AIDS Malignancy Consortium (AMC)-059 Study Team
Jeannette Y Lee
Michelle A Rudek
Rachel A Bender Ignacio
Richard F Ambinder
Susan E Krown
P2860
P356
10.1097/QAI.0000000000000918
P407
P50
P577
2016-05-01T00:00:00Z